Effects of transcutaneous electrical nerve stimulation on motor and sensorial nerves for diabetic polyneuropathy patients by use of electromyography

Yıl 2010, Cilt: 2 Sayı: 3, 112 - 116, 14.08.2013

Servet Kavak Metin Tulgar Ömer Anlar - -

Öz

About 20–30% of diabetic patients are affected by DP. Transcutaneous electrical nerve stimulation (TENS) and electrical has been proposed as physical therapies. This study
was aimed to investigate the effects of high rate frequency modulation (HRFM) with TENS treatment on patients which have diabetic polyneuropathy (DP).
Patients with type 2 diabetes and DP (n=14) both upper extremities were treated for 20 min daily for twenty consecutive days. The patients' values of glucose, amplitude
and latency were measured by use of EMG at before TENS, after TENS and following term of TENS. Patients were similar
in terms of baseline characteristics, such as age, duration of diabetes, neurological symptoms scores and neurological disability scores. Differences among glucose levels related to before TENS, after TENS and following term of TENS are found statistically significant (p<0.05). Differences for amplitude did not change statistically. Differences on latencies belong to motor and sensorial nerves were found statistically significant (p<0.05).
In conclusion, result of the study indicated that TENS treatment has been positive effect on diabetic polyneuropathy.

Anahtar Kelimeler

Diabetes, pain, polyneuropathy, transcutaneous electrical nerve stimulation

Kaynakça

• Abuaisha BB, Costanzl JB, Boulton AJ. 1998. Acupuncture for the treatments of chronic painful peripheral diabetic neuropathy: a long term study. Diabetes Res Clin Pract 39: 115-121
• American Diabetes Association Clinical practice recommendations screening for diabetes. 1995. Diabetes Care 18 Suppl.1, 5-7
• Apfel SC, Asbury AK, Bril V. 2001. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci 189: 3–5
• Armstrong DG, Lavery LA. Fleischii JG, Gilhain KA. 1997. Is electrical stimulation effective in reducing neuropathic pain in patients with diabetes. J Foot Ankle Surg 36: 260-263
• Bonnefont-Rousselod D, Beaudeux JL, Therond P, Peynet J, Legrand A, Delattre J. 2004. Diabetes mellitus, oxidative stress and advanced glycation endoproducs. Ann Pharm Fr 62:147-57
• Greene D, Sima A, Albers J, Pfeifer, M. 1990. Diabetic neuropathy. In Diabetes Mellitus the Ory and Practice 4th ed. Ellenberg M. Rifkin H, Porte D, Eds. New York, Elsevier p.710-755
• Harris M, Eastman R, Cowie C. 1993. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 16:1446–1452
• Kumar D, Marshall HJ. 1997. Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation. Diabetes Care 20:1702-1705
• Martyn CN, Reid W. Young RJ. Ewing DJ, Clarke BF. 1987. Six month treatment with sorbinil in asymptomatic diabetic neuropathy: failure to improve abnormal nerve function. Diabetes 36:987-990
• Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. 1992. Effects of desipramme, amitriptyline and fluoxetine on pain in diabetic neuropathy. N Engl J Med 26:1250-1256
• Mima T, Oga T, Rothwell J. 2004. Short-term highfrequency transcutaneous electrical nerve stimulation decreases human motor cortex excitability. Neurosci Lett 355: 85–88
• Neumann V. 1993. Electrotherapy (Editorial). Br J Rheumatol 32:1.
• Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J and MacFarlane JA. 1996. Electrical. spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet 348:1696-1701
• Tulgar M. 1992. Advances in electrical nerve stimulation techniques to manage chronic pain: An overview. Advances in Therapy 9:366-372.
• Vinik AI. 2004. Diabetic neuropathies. Med Clin N Am 88:947–999
• Watkins PJ. 1984. Somatic neuropathies. Diabetes Care 27:1458–1486
• Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH. 1993. A. multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:1–5.